CBD Regulation

How CBD is Regulated for Pet Use

October 4, 2019 1.5 min read

Download or Print Page

What do the laws say?

Currently, there are no approved drugs containing CBD for animals (including pets). There is only one approved drug product for human use that contains CBD and that is Epidiolex, for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients 2 years of age and older. The Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA) permits veterinarians to prescribe extralabel uses (i.e., uses not in accordance with approved labeling) of approved human drugs for animals under certain conditions. Among other limitations, extralabel use of a drug requires the lawful order of a licensed veterinarian in the context of a valid veterinarian-client-patient relationship and only in circumstances when the health of an animal is threatened or suffering, or death may result from failure to treat.

Most United States (U.S.) veterinary medical licensing and pharmacy boards are advising veterinarians to avoid discussing, recommending and selling products containing CBD until further guidance is provided by the U.S. Food and Drug Administration (FDA). This is because, under federal law, there are no approved uses of CBD for animals (including pets). However, laws across U.S. states vary and in August 2019, the state of California proposed a Bill (California Senate Bill 267) to authorize veterinarians to recommend cannabis and cannabis products for medicinal uses in animals.  

When it comes to an individual pet, no one knows their specific health needs better than the veterinarian. Before administering any CBD products, we recommend consulting your veterinarian. While veterinarians can’t recommend a CBD product, yours may be willing to at least have a conversation about the best decision for your pet’s specific health needs. 

There is hope that the future holds an environment where the door is open for conversations between veterinarians and clients regarding CBD. 

The regulatory landscape for CBD is evolving. We will continue to update this section with the latest information.

The information provided on this website does not, and is not intended to, constitute legal advice; instead, all information, content, and materials available on this site are for general informational purposes only. Information on this website may not constitute the most up-to-date legal or other information.